The Dannemiller Memorial Educational Foundation designates this educational activity for a maximum of 3 category 1 credits toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

This activity should take approximately 3 hour(s) to complete. The participant should, in order, read the objectives and monograph, answer the online multiple-choice post-test, and complete the answer form, registration, and evaluation. This credit is valid through October 31, 2004.

For questions regarding the content of this activity, contact Dannemiller Memorial Educational Foundation, accredited provider for this CME/CE activity, at edd@pain.com. For technical assistance, contact support@cecity.com.

This educational activity contains discussion of published and/or investigational uses of prokinetic agents for the treatment of GERD in children; tricyclic antidepressants, tegaserod, alosetron, and cilansetron for the treatment of NEED; high-dose proton pump inhibitor (PPI) therapy for the treatment of erosive esophagitis; ablative therapies—thermal, chemical, or mechanical—for Barrett’s esophagus; and omeprazole, lansoprazole, buspirone, sumatriptan, domperidone, and tricyclic antidepressants for the treatment of functional dyspepsia. Some uses of these agents have not been approved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

The McMahon Publishing Group, New York City © 2003.

All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means—electronic, mechanical, photocopying, recording, or otherwise—without prior permission of the copyright owner.

The use of general descriptive names, trade names, trademarks, etc, in this publication, even if they are not specially identified, is not to be taken as a sign that such names, as understood by the Trade Marks and Merchandise Marks Act, may accordingly be used freely by anyone.

While the advice and information in this book are believed to be true and accurate at the date of going to press, neither the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, expressed or implied, with respect to material contained herein.